Tomas J. Heyman has been a director since May 2023. Since 2021, Mr. Heyman has served as a consultant to Interlaken Therapeutics, Inc., a biotechnology company, and as its interim Chief Executive Officer. Since 2020, Mr. Heyman has served as Operating Partner at Bioqube Ventures, a life sciences investment firm. Previously, Mr. Heyman served as the President of Johnson & Johnson’s Corporate Venture Capital Group, the venture capital arm of Johnson & Johnson, a pharmaceutical and consumer packaged goods company, from 2015 to 2019, and as the Global Head of Business Development for Johnson & Johnson’s Pharmaceutical Group from 1992 to 2015. Mr. Heyman also served as Managing Director of Janssen Pharmaceutica, a pharmaceutical company and an affiliate of Johnson & Johnson, from 2008 to 2016. Mr. Heyman began his career as a member of the legal department of Janssen Pharmaceutica NV in 1982. Mr. Heyman has served as the non-executive chairman of the board of directors of Venatorx Pharmaceuticals, Inc., a pharmaceutical company, since 2023, and as a member of the board of directors of Legend Biotech Corporation, a biotechnology company, since 2022, and Xilio Therapeutics, Inc., a biotechnology company, since 2022, and Invivyd, Inc. (formerly Adagio Therapeutics), a biopharmaceutical company, since 2021, and OptiNose, Inc., a specialty pharmaceutical company, since 2020, and Akero Therapeutics, Inc., a biotechnology company, since 2020. In the not-for-profit sector, Mr. Heyman has served as a member of the board of directors of Interuniversitair Micro-Electronica Centrum VZW, a Belgian non-profit organization specializing in micro- and nano-electronic research, since 2012. Previously, Mr. Heyman served as a member of the Supervisory Board of Crucell NV, a biotechnology company, and as a member of the board of directors of the International Biomedical Research Alliance, a non-profit organization focused on biomedical research. Mr. Heyman holds a Master of Laws from Katholieke Universiteit Leuven. He continued with post-graduate studies in International Law in Geneva, Switzerland, and post-graduate studies in Business Management at the University of Antwerp in Belgium.